Marcus Boehm, Director at Vyant Bio, Inc. (VYNT), bought 98,786 shares at $3.76 ($19K) on 2021-06-30, disclosed to the SEC on 2021-07-01.
Scheduled purchase ($19k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 78,263 | $0 | 0.0% |
| 2 | $0.00 | 15,523 | $0 | 0.0% |
| 3 | $3.76 | 5,000 | $19K | 100.0% |
| Total | $0.19 avg | 98,786 | $19K | 100% |
| Filing → |
| VYNT | BUY | 2021-09-30 | $12K | — | Filing → |
| VYNT | BUY | 2021-08-26 | $13K | — | Filing → |
| VYNT | BUY | 2021-07-28 | $15K | — | Filing → |